Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Clinical study

Higher bodyweight increases risk of acute kidney injury

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In patients receiving combination therapy with piperacillin/tazobactam and vancomycin, higher bodyweight appears to be associated with an increased risk of acute kidney injury (AKI), according to findings of a retrospective US study published in the American Journal of Health-System Pharmacy. …
Literatur
Zurück zum Zitat Rutter WC, et al. Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin. American Journal of Health-System Pharmacy 76: 1211-1217, No. 16, Aug 2019. Available from: URL: http://doi.org/10.1093/ajhp/zxz120 Rutter WC, et al. Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin. American Journal of Health-System Pharmacy 76: 1211-1217, No. 16, Aug 2019. Available from: URL: http://​doi.​org/​10.​1093/​ajhp/​zxz120
Metadaten
Titel
Higher bodyweight increases risk of acute kidney injury
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65765-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Doxorubicin

Case report

Multiple drugs

Case report

Pyrantel